Silva João Miguel de Almeida, Silva Cecília Pereira, Melo Flavio Fernando Nogueira de, Silva Luis Alberto A, Utagawa Claudia Yamada
Curso de Medicina do Centro Universitário de Volta Redonda, RJ, Brasil.
Arq Bras Endocrinol Metabol. 2010 Aug;54(6):572-7. doi: 10.1590/s0004-27302010000600011.
The 22q11.2 deletion syndrome (22q11.2DS) is related to a high phenotypic variability including the velocardiofacial/DiGeorge spectrum. Autoimmune, endocrine and immunodeficiency manifestations have been reportedly associated with the syndrome. The objective of this study was to report a case of 22q11.2DS associated with IgA deficiency and Graves disease and review literature in order to verify the frequency of syndrome alterations. Autoimmune disorders have been increasingly related to 22q11.2DS, and new phenotypes are being incorporated in the clinical spectrum of this syndrome. In our study we found that Graves disease in association with 22q11.2DS was reported in only sixteen patients, and fifteen cases were described in the last 13 years. Based on the incidence and on the amplitude of this recognized spectrum, we reinforce the findings of literature that Graves disease should be included on the 22q11.2DS manifestations, which would lead us to seek it with 22q11.2 deletion patients.
22q11.2缺失综合征(22q11.2DS)与包括腭心面/迪乔治综合征在内的高度表型变异性有关。据报道,自身免疫、内分泌和免疫缺陷表现与该综合征相关。本研究的目的是报告一例与IgA缺乏症和格雷夫斯病相关的22q11.2DS病例,并回顾文献以核实综合征改变的频率。自身免疫性疾病与22q11.2DS的关系日益密切,新的表型也被纳入该综合征的临床谱中。在我们的研究中,我们发现仅16例患者报告了与22q11.2DS相关的格雷夫斯病,且在过去13年中描述了15例。基于这一已确认谱的发病率和范围,我们强化了文献中的发现,即格雷夫斯病应被纳入22q11.2DS的表现中,这将促使我们在22q11.2缺失患者中寻找该病。